Bluesail Surgical Selected for the List of Shanghai’s Specialized and Sophisticated Enterprises

Recently, the list of Shanghai’s Specialized and Sophisticated Small and Medium-sized Enterprises for 2024 (the second batch) was announced. This evaluation aims to enhance the innovation capability and specialization level of small and medium-sized enterprises, promote high-quality development, and help achieve the advanced development of industrial foundations and modernization of industrial chains. Bluesail Surgical Instruments Co., Ltd., (‘Bluesail Surgical’ for shorted) an investment-incubated company under Bluesail Medical, was recognized as one of the "2024 Shanghai Specialized and Sophisticated Small and Medium-sized Enterprises " This recognition acknowledges the company’s achievements in innovative research and development, as well as its focus on cultivating technological talent. It marks the company’s outstanding performance in innovation capacity and R&D strength.

The term "Zhuan Jing Te Xin" refers to enterprises that demonstrate a high level of specialization, refinement, uniqueness, and innovation. These companies often have a deep focus on specific niche markets, strong innovation capabilities, high market share, and mastery of key core technologies. They play a crucial role in supporting industrial and supply chains and are a driving force for regional industrial development.

Bluesail Surgical, established through investment by Bluesail Medical, aims to continually enhance the overall competitive strength of Bluesail Medical in the high-value consumables sector. With a clear corporate strategy and strong organizational execution, Bluesail Surgical has committed to a path of original design and independent mass production. The company has successfully launched core surgical products, including the RenoVue® / RenoPort® novel intra-abdominal lens cleaning device, the Siderlux® and Astrolux® powered articulating endoscopic linear cutter, and the TisFree® ultrasonic scalpel system. Thanks to its robust R&D capabilities, Bluesail Surgical has introduced six major product lines, covering a wide range of medical devices and consumables, from traditional to modern, meeting the diverse medical needs of various countries and regions worldwide. Notably, the company has independently developed several innovative products that lead the industry in technology, significantly enhancing medical efficiency and improving patient experiences. These contributions have played a vital role in advancing global healthcare. Looking ahead, the company plans to launch 2 to 3 impactful new products annually over the next five years, further consolidating and expanding its leadership position in the global medical market.

Bluesail Surgical not only continuously launches innovative products, and leading industry trends, but also actively integrates global expert resources. The company has extended prestigious invitations to top experts from home and abroad to participate in academic lectures and provide surgical guidance, promoting knowledge exchange and the integrity of techniques. Among these initiatives, the multi-dimensional collaboration has been established over the past two years with Professor Diego Gonzalez Rivas, a pioneer in Uniportal VATS technique in the global field of thoracic surgery, which has provided doctors with cutting-edge medical knowledge and skills.

Driven by a strong sense of social responsibility and a commitment to long-term growth, in response to the state's efforts to improve the level of minimally invasive treatment in primary medical care, Bluesail Surgical collaborated with the National Health Commission of the People's Republic of China to initiate the "Standardized Training Program for Endoscopic Techniques at Primary Medical Institutions."

The program aims to elevate the diagnostic and treatment levels of primary healthcare facilities, foster academic exchange among grassroots medical staff, and strengthen the support and guidance from top-tier hospitals in major cities to grassroots hospitals, ultimately helping local healthcare providers improve their minimally invasive surgical skills. The program spans 21 provinces and organizes over 100 leading domestic experts to train grassroots medical surgeons nationwide in endoscopic techniques. Nearly a thousand surgeons have greatly benefited from this initiative, significantly advancing the level of minimally invasive care in primary healthcare settings.

As a globally-oriented medical device company, Bluesail Surgical boasts a business network spanning over 60 countries across four continents, underscoring its significant influence in the international market. Domestically, Bluesail Surgical’s operations cover 31 provinces, municipalities, and autonomous regions in China, with strong partnerships established with more than 1,200 hospitals. This extensive network not only reflects the company’s deep penetration into the domestic healthcare field but also highlights the widespread recognition of its products and services.

Bluesail Surgical’s mission is to bring the innovation and outstanding of Chinese-made surgical instruments to the world, showcasing the strength of "Made in China" on the global medical stage. Through participation in international exhibitions, deepening academic exchanges, and expanding clinical collaborations, we are continuously enhancing the international image of Bluesail Surgical. Our goal is to establish the brand as the preferred choice in the global medical field. Our commitment to expanding into international markets remains steadfast, driven by the vision to enable healthcare institutions and patients worldwide to benefit from the efficiency and safety of Chinese surgical instruments. The ultimate vision of Bluesail Surgical is to become the leading global brand in the medical field, delivering superior healthcare to patients across the world.